Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.95 USD | +1.63% | -0.92% | +17.67% |
02/05 | Wedbush Raises SpringWorks Therapeutics' Price Target to $75 From $70, Keeps Outperform Rating | MT |
02/05 | SpringWorks Therapeutics Shares Fall After Wider-Than-Expected Q1 Loss | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.67% | 3.13B | |
+2.97% | 108B | |
+10.21% | 105B | |
+1.57% | 23.46B | |
-12.77% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.50% | 17.19B | |
+6.00% | 13.99B | |
+37.20% | 12.53B |
- Stock Market
- Equities
- SWTX Stock
- News SpringWorks Therapeutics, Inc.
- Springworks Therapeutics Insider Sold Shares Worth $1,160,362, According to a Recent SEC Filing